34 studies found for:    2502
Show Display Options
Rank Status Study
1 Completed Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients
Condition: Chagas Disease
Interventions: Drug: Nifurtimox (BAYa2502) (4 x 30 mg tablet);   Drug: Nifurtimox (BAYa2502) (slurry of 4 x 30 mg tablets in tap water);   Drug: Nifurtimox (BAYa2502) (120 mg tablet)
2 Recruiting Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma or Hodgkin Lymphoma
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Hodgkin Lymphoma
Interventions: Drug: bendamustine hydrochloride;   Drug: carboplatin;   Biological: rituximab;   Drug: etoposide;   Other: laboratory biomarker analysis
3 Completed
Has Results
A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy
Condition: Moderate to Severe Pain Due to Diabetic Polyneuropathy
Interventions: Drug: Oxycodone Naloxone;   Drug: Placebo tablets
4 Completed Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: COLAL-PRED®;   Drug: Prednisolone
5 Recruiting Radiogenomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
Condition: Lung Cancer
Intervention:
6 Completed Can Structured Education Promote Physical Activity in Those Identified With an Increased Risk of Developing Diabetes
Condition: Prediabetic State
Interventions: Behavioral: PREPARE with pedometer;   Behavioral: PREPARE
7 Completed
Has Results
Irinotecan Study For Cervical Cancer
Condition: Uterine Cervical Neoplasms
Intervention: Drug: Irinotecan
8 Completed GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: DOCETAXEL
9 Completed NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)
Condition: Head and Neck Neoplasms
Intervention: Drug: DOCETAXEL(XRP6976)
10 Completed TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian
Condition: Ovarian Neoplasms
Intervention: Drug: Docetaxel
11 Unknown  Methods of Improvement Adherence With Therapy in Ulcerative Colitis.
Condition: Ulcerative Colitis
Intervention: Behavioral: Range of electronic pill dispensers with alarms
12 Terminated The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)
Conditions: Gastroesophageal Reflux Disease;   Non-erosive Reflux Disease
Intervention: Drug: Pantoprazole
13 Completed
Has Results
A Study in Painful Diabetic Neuropathy
Condition: Diabetic Neuropathy, Painful
Interventions: Drug: Duloxetine;   Drug: Pregabalin;   Drug: Placebo
14 Completed Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)
Condition: Gastroesophageal Reflux Disease (GERD)
Intervention: Drug: Pantoprazole
15 Completed A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: Platinum-based chemotherapy
16 Completed
Has Results
Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain
Condition: Central Neuropathic Pain
Interventions: Drug: Pregabalin;   Drug: Placebo
17 Completed
Has Results
Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia.
Condition: Fibromyalgia
Interventions: Drug: pregabalin;   Drug: placebo
18 Completed To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.
Condition: Neuropathic Pain
Intervention: Drug: Pregabalin
19 Terminated
Has Results
Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design
Condition: Spinal Cord Injuries
Interventions: Drug: Pregabalin;   Drug: Placebo for pregabalin
20 Completed A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer.
Condition: Breast Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: Taxane-based chemotherapy

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Indicates status has not been verified in more than two years